HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

epsilon-N-1-(1-deoxylactulosyl)lysine

beta-galactosidase substrate

Also Known As:

epsilon-(deoxylactulose)lysine; lactose-lysine; lactulose-lysine; lactuloselysine

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Oligosaccharides: 3566
    - Disaccharides: 990
      - Lactulose: 1367
        epsilon-N-1-(1-deoxylactulosyl)lysine: 1
- Sugars: 11126
  - Disaccharides: 990
    - Lactulose: 1367
      - epsilon-N-1-(1-deoxylactulosyl)lysine: 1

Experts

1.	Deppisch, Reinhold: 1 article (02/2006)
2.	Henle, Thomas: 1 article (02/2006)
3.	Klein, Wolfgang: 1 article (02/2006)
4.	Morath, Christian: 1 article (02/2006)
5.	Ritz, Eberhard: 1 article (02/2006)
6.	Schwenger, Vedat: 1 article (02/2006)
7.	Schönfelder, Kathrin: 1 article (02/2006)
8.	Weigel, Kai: 1 article (02/2006)
9.	Zeier, Martin: 1 article (02/2006)

Related Diseases

1.

Renal Insufficiency (Renal Failure)

02/01/2006 - "Although the findings exclude accumulation of lactuloselysine in renal failure, they do not generally exclude accumulation of other food-derived advanced glycation end products (AGEs)."
02/01/2006 - "In healthy individuals, ingestion of lactuloselysine bound to food proteins caused only a minor acute increase (8.24+/-1.11 mg/day, 2% of the administered dose) of AP excretion in the urine; in patients with renal failure not yet on dialysis, the increase in AP excretion in the urine was significantly less (4.0+/-0.51 mg/day) and the same was true in CAPD patients (0.21+/-0.09 mg/day). "

Related Drugs and Biologics

1.	Advanced Glycation End Products
2.	Proteins (Proteins, Gene)

Related Therapies and Procedures

1.	Continuous Ambulatory Peritoneal Dialysis (CAPD)